Foresee Pharmaceuticals Co., Ltd. Share Price
Equities
6576
TW0006576002
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
95 TWD | -0.11% | +1.50% | -1.25% |
Sales 2024 * | 916M 28.12M 2.25B | Sales 2025 * | - | Capitalization | 12.9B 396M 31.68B |
---|---|---|---|---|---|
Net income 2024 * | -76M -2.33M -187M | Net income 2025 * | - | EV / Sales 2024 * | 14.2 x |
Net Debt 2024 * | 116M 3.56M 285M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-148
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.79% |
1 day | -0.11% | ||
1 week | +1.50% | ||
Current month | -3.06% | ||
1 month | -1.66% | ||
3 months | +1.50% | ||
6 months | +16.56% | ||
Current year | -1.25% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Hua Li
FOU | Founder | - | 08/07/15 |
Benjamin Chien
CEO | Chief Executive Officer | - | 07/02/13 |
Max Chan
DFI | Director of Finance/CFO | 56 | 06/10/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lee
BRD | Director/Board Member | 73 | 02/08/15 |
Benjamin Chien
CEO | Chief Executive Officer | - | 07/02/13 |
Fu Shiow Yin
BRD | Director/Board Member | - | 30/03/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 95 | -0.11% | 126,877 |
25/04/24 | 95.1 | 0.00% | 89,610 |
24/04/24 | 95.1 | +1.06% | 121,376 |
23/04/24 | 94.1 | +0.11% | 131,750 |
22/04/24 | 94 | +0.43% | 198,885 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.25% | 396M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 6576 Stock